Related Experiment Video
Updated: Jun 28, 2025

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
Published on: December 29, 2021
Medicinal cannabis in neurodegenerative disorders: an open label, dose finding, safety and efficacy study
Peter K Panegyres1,2, Kerry L Lind1, Cheryl A MacFarlane1
1Neurodegenerative Disorders Research Pty Ltd, West Perth, 6005, Western Australia.
Abstract:
Aim: Currently, there exist no curative treatments for neurodegenerative disorders. Recently, there has been a resurgence of interest in the use of medicinal cannabis to improve neurological conditions. Methods: A 12-month, open label, dose-finding, safety and efficacy study was conducted including 48 subjects with a variety of neurodegenerative disorders. Results: In our participants, we observed a reduction in pain, improved sleep, enhanced well-being and less agitation. Conclusion: Our findings suggest that medicinal cannabis might be useful in patients with neurodegenerative disorders in controlling pain, enhancing sleep, reducing difficult behaviors, controlling unusual and complex symptoms when other treatments have failed - this offers medicinal cannabis a role in palliation.
Related Concept Videos
Alzheimer's Disease: Treatment
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...

